This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheralarterydisease (PAD), a condition in which plaque builds up in arteries in the legs.
We aimed to compare the sensitivity and specificity of different ankle-brachial index (ABI), toe-brachial index (TBI), and ecfPWV measurement methodologies to evaluate their contribution to peripheralarterydisease (PAD) screening. Results ROC analysis exhibited a sensitivity/specificity of 70.6%/98.1%
Publication date: Available online 12 June 2024 Source: The American Journal of Cardiology Author(s): Ashish Kumar, Mariam Shariff, Monil Majmundar, John M. Stulak, Nandan Anavekar, Abhishek Deshmukh, Riyaz Bashir
The goal of this pivotal study is to evaluate the safety and efficacy of using this device that integrates laser atherectomy and intravascular lithotripsy in a single device to treat complex, calcified lesions in a single procedure for patients with peripheralarterydisease (PAD), restoring blood flow to their legs.
PTA+DCB, P Key findings include: · One-year primary patency (freedom from both clinically driven target lesion revascularization and duplex ultrasound-derived restenosis) did not differ between groups, despite the significant difference in baseline calcification. · DA+DCB versus 5.9% versus 21.1%, P =0.014). 3 · One-year rates of TLR (16.6%
The roundtable provided a unique opportunity to identify knowledge gaps and discuss how IVUS can enhance our understanding and treatment of peripheralarterial and deep venous pathology." Participants agreed that treatment standards, formal training programs and global quality metrics remain needed to improve patient care.
Most have gotten used to egregiously bad coverage of current events that fills the pages of today’s New York Times, but even by their now very low standards a recent telling of a story about peripheralarterydisease was very bad. A second opinion from another physician at another facility resulted in a normal ultrasound.
Common Vascular Conditions We Treat Some vascular diseases affect your arteries while others occur in your veins. Atherosclerosis & ArterialDiseasesPeripheralArteryDisease (PAD) : A blockage in your legs. Carotid ArteryDisease : A blockage or narrowing in the arteries supplying your brain.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content